These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


412 related items for PubMed ID: 10695795

  • 21. Clinical implications of viral activity in dual infection with hepatitis B and C in chronic liver disease.
    Guptan RC, Thakur V, Malhotra V, Sarin SK.
    J Assoc Physicians India; 2002 May; 50(5):651-5. PubMed ID: 12186118
    [Abstract] [Full Text] [Related]

  • 22. [Efficacy and safety of vaccination against hepatitis A and B in patients with chronic liver disease].
    de Artaza Varasa T, Sánchez Ruano JJ, García Vela A, Gómez Rodríguez R, Romero Gutiérrez M, de la Cruz Pérez G, Gómez Moreno AZ, Carrobles Jiménez JM.
    Gastroenterol Hepatol; 2009 May; 32(7):483-8. PubMed ID: 19577338
    [Abstract] [Full Text] [Related]

  • 23. [HAV infection in patients with chronic hepatitis C].
    Bertino G, Ardiri AM, Bruno MC, Valenti M, Lerna D, Boemi PM, Interlandi D, Urso G, Fisichella A, Pulvirenti D, Neri S.
    Clin Ter; 2007 May; 158(3):223-5. PubMed ID: 17612281
    [Abstract] [Full Text] [Related]

  • 24. Prevalence of markers of hepatitis viruses A, B, C and of HIV in healthy individuals and patients of a Cambodian province.
    Thüring EG, Joller-Jemelka HI, Sareth H, Sokhan U, Reth C, Grob P.
    Southeast Asian J Trop Med Public Health; 1993 Jun; 24(2):239-49. PubMed ID: 7505485
    [Abstract] [Full Text] [Related]

  • 25. Viral hepatitis in India.
    Acharya SK, Madan K, Dattagupta S, Panda SK.
    Natl Med J India; 2006 Jun; 19(4):203-17. PubMed ID: 17100109
    [Abstract] [Full Text] [Related]

  • 26. Comparison of hepatitis A seroprevalence in blood donors in South Tunisia between 2000 and 2007.
    Louati N, Feki L, Rekik H, Feki H, Chaabouni M, Hammami A, Gargouri J, Karray-Hakim H.
    Arch Inst Pasteur Tunis; 2009 Jun; 86(1-4):69-74. PubMed ID: 20707222
    [Abstract] [Full Text] [Related]

  • 27. Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong.
    Wong KH, Liu YM, Ng PS, Young BW, Lee SS.
    J Med Virol; 2004 Apr; 72(4):538-44. PubMed ID: 14981755
    [Abstract] [Full Text] [Related]

  • 28. [The prevalence of hepatitis G virus in patients with hepatitis B and C virus infections].
    Kaya S, Cicioğlu Aridoğan B, Demirci M.
    Mikrobiyol Bul; 2004 Oct; 38(4):421-7. PubMed ID: 15700668
    [Abstract] [Full Text] [Related]

  • 29. Seroprevalence of hepatitis A virus markers in Eastern Saudi Arabia.
    Fathalla SE, Al-Jama AA, Al-Sheikh IH, Islam SI.
    Saudi Med J; 2000 Oct; 21(10):945-9. PubMed ID: 11369959
    [Abstract] [Full Text] [Related]

  • 30. Hepatitis E virus superinfection in patients with chronic liver disease.
    Hamid SS, Atiq M, Shehzad F, Yasmeen A, Nissa T, Salam A, Siddiqui A, Jafri W.
    Hepatology; 2002 Aug; 36(2):474-8. PubMed ID: 12143058
    [Abstract] [Full Text] [Related]

  • 31. Prevalence of hepatitis A, B, C, and E antibody in flying airline personnel.
    Andenaes S, Lie A, Degré M.
    Aviat Space Environ Med; 2000 Dec; 71(12):1178-80. PubMed ID: 11439715
    [Abstract] [Full Text] [Related]

  • 32. [Prevalence of hepatitis A virus antibodies in hospital personnel].
    Abb J.
    Gesundheitswesen; 1994 Jul; 56(7):377-9. PubMed ID: 7919699
    [Abstract] [Full Text] [Related]

  • 33. Seroepidemiology of hepatitis A in patients with chronic liver disease.
    Saab S, Lee C, Shpaner A, Ibrahim AB.
    J Viral Hepat; 2005 Jan; 12(1):101-5. PubMed ID: 15655056
    [Abstract] [Full Text] [Related]

  • 34. Hepatitis A, B, and C infection in a community of sub-Saharan immigrants living in Verona (Italy).
    Majori S, Baldo V, Tommasi I, Malizia M, Floreani A, Monteiro G, Ferrari A, Accordini A, Guzzo P, Baldovin T.
    J Travel Med; 2008 Jan; 15(5):323-7. PubMed ID: 19006505
    [Abstract] [Full Text] [Related]

  • 35. Viral hepatitis in South African healthcare workers at increased risk of occupational exposure to blood-borne viruses.
    Vardas E, Ross MH, Sharp G, McAnerney J, Sim J.
    J Hosp Infect; 2002 Jan; 50(1):6-12. PubMed ID: 11825045
    [Abstract] [Full Text] [Related]

  • 36. Changing seroepidemiology of hepatitis A virus infection in Thailand.
    Poovorawan Y, Theamboonlers A, Chumdermpadetsuk S.
    Southeast Asian J Trop Med Public Health; 1993 Jun; 24(2):250-4. PubMed ID: 8266225
    [Abstract] [Full Text] [Related]

  • 37. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B, Takahashi M, Nishizawa T, Endo K, Inoue J, Okamoto H.
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [Abstract] [Full Text] [Related]

  • 38. Vaccination for hepatitis A virus is not required for patients with chronic liver disease in India.
    Acharya SK, Batra Y, Saraya A, Hazari S, Dixit R, Kaur K, Bhatkal B, Ojha B, Panda SK.
    Natl Med J India; 2002 Dec; 15(5):267-8. PubMed ID: 12502138
    [Abstract] [Full Text] [Related]

  • 39. Prevalence of human cytomegalovirus co-infection in patients with chronic viral hepatitis B and C: a comparison of clinical and histological aspects.
    Bayram A, Ozkur A, Erkilic S.
    J Clin Virol; 2009 Jul; 45(3):212-7. PubMed ID: 19497785
    [Abstract] [Full Text] [Related]

  • 40. The prevalence of atopy in children with antibodies against hepatitis A virus and hepatitis B virus.
    Kocabaş E, Yapicioğlu H, Yildizdaş D, Güneşer Kendirli S, Burgut R.
    Turk J Pediatr; 2006 Jul; 48(3):189-96. PubMed ID: 17172060
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 21.